The post Toward a Global Research Plan for Preventing Multiple Sclerosis appeared first on MS Australia. Source: www.msaustralia.org.au

You see, in my head, my resolutions have already borne plenty of success. In reality, crippling fatigue and facial nerve pain have halted even more tasks, projects and mighty dreams, but, LGO*. Source: irelandms.com

The National Institute for Health and Care Excellence (NICE) in England is recommending natalizumab — sold as Tysabri and Tyruko — as an option for certain people with hard-to-control multiple sclerosis (MS). NICE is responsible for deciding which medicines will be covered by the National…

Women with multiple sclerosis (MS) who have children experience significantly longer waits before receiving a diagnosis than women without children, according to a new U.S. study. On average, each child was associated with an additional 1.28-year delay in diagnosis. The delay was even longer among…

Tweet Metformin has become flavour of the month trial and there are numerous studies ongoing or recently completed. Here they have done a study of metformin plus beta interferon and say that there was no evident benefit….Should we fear for Octopus the MS trial in…

The post International experts chart global strategy to prevent multiple sclerosis appeared first on MS Australia. Source: www.msaustralia.org.au

Tiziana Life Sciences‘ intranasal spray foralumab continues to be safe and well-tolerated, with no drug-related serious side effects reported after long-term use, according to an annual report filed with the U.S. Food and Drug Administration (FDA). The company is developing foralumab for neuroinflammatory diseases such…

Happy first Monday of 2026! The New Year is already off to an unusual start. Before I delve into too much detail, 2025 is now in our past, which I am thankful for, as it was not the best year. Of course, the past several years…